Skip to content
Open access

Bayesian probabilistic statements for communicating clinical trial results

Oct 2026 · BMC Medicine · Vol 24 · 0 citations · 34 references
Medicine

TL;DR

This work empirically evaluate the utility of probabilistic statements by re-analyzing data from previously published trials using Bayesian methods, and provides instructional examples of how probabilistic statements can be used to communicate and interpret results from clinical trials.

Abstract

Clinical trials are often analyzed using frequentist methods and results are interpreted according to their statistical significance. However, p-values and effect measures such as odds or hazard ratios are poorly understood by researchers and policymakers, and even less by patients and clinicians. Moreover, communicating uncertainty around treatment effects is challenging. Probabilistic statements from Bayesian analyses (e.g., the probability that a drug is more effective than placebo) offer an intuitive way to convey results and uncertainty, may provide insight, and support clinical decision-making. We aimed to (i) empirically evaluate the utility of probabilistic statements by re-analyzing data from previously published trials using Bayesian methods, and (ii) provide instructional examples of how probabilistic statements can be used to communicate and interpret results from clinical trials. We analyzed data on primary outcomes obtained from trials previously published in leading medical journals, using Bayesian methods. We included 169 primary outcomes from 130 negative trials (p-values > 0.05) across various medical fields, and 234 outcomes from 225 positive trials (p-value < 0.05) in oncology. We used uninformative priors for illustration, supplementing them with skeptical priors in sensitivity analyses. We estimated the probabilities that active treatments were more effective or safe than controls, for each outcome. We also estimated probabilities that the treatment effects were above specific thresholds for clinical significance. We described three of the included trials in more detail and additionally analyzed one trial in neurology as didactical case studies, to illustrate the use of probabilistic statements. So-called negative studies may sometimes yield clinically relevant evidence of an effect: in 26/169 (15%) cases we found > 90% probability that the experimental treatment is better than control; for 12/169 (7%) of them, this probability was > 95%. Conversely, positive trials may not always show evidence of clinically meaningful effects: in 25/234 (11%) of the positive oncology trials, there was less than 50% probability that treatment reduces hazards by 20% or more. Our case studies illustrate how to use probabilistic statements in medical decision making in practice. Relying on statistical significance without considering clinical importance can mislead decision-making and potentially harm patients. Probabilistic statements from Bayesian analyses can complement traditional approaches to communicating clinical trial results.

Read PDF

Similar papers

Open access Oct 2026

Probabilistic interpretation of clinical trial results to improve interpretation and communication of findings

Clinical trials are usually analyzed using frequentist methods and interpreted through p-values, which are often poorly understood. In contrast, Bayesian analyses yield probabilistic statements that offer a more intuitive interpretation of treatment effects and uncertainty. To demonstrate the utility of pr...

G. Siontis, K. Chalkou, T. Perneger et al. · 0 citations
Open access Sep 2026

Bayesian re-analysis suggests participation rather than referral underlies the benefits of social prescribing for chronic diseases

Background Social prescribing (SP) is increasingly implemented to address the social determinants of health in people with chronic diseases, yet uncertainty remains regarding its effectiveness and the mechanisms through which benefit is achieved. We performed a Bayesian re-analysis of randomized trials to distinguish o...

Mei Huang, Guang-Qing Fu, Zhen Du · 0 citations
Review Nov 2026

Estimating Marginal Effects on Survival Outcomes for Clinical Interpretations and Decision Making.

A marginal effects framework to generate adjusted cumulative incidence curves that are coherent with the analysis model, anchored in absolute risk estimates, and adaptable to competing risks and clustered data is described.

Shan-Shan Liu, C. Yek, Mei-Cheng Wang et al. · 0 citations
Review Open access Oct 2026

Interpreting P values in clinical research: A practical guide for clinicians

Clinicians and researchers are provided with a practical framework for evaluating statistical findings in medical studies through the basic principles of P values, common misconceptions, statistical errors, practices that threaten scientific validity, and complementary statistical approaches that can improve clinical i...

A. Şener · 0 citations
Review Open access Sep 2026

Prediction or explanation: a clinician's guide to logistic regression.

This article reviewed papers published in the Korean Journal of Anesthesiology between 2021 and 2024 that used logistic regression and examined reporting practices, focusing on whether the model evaluation was consistent with the stated analytical purpose.

J. In, Dong Kyu Lee · 0 citations
Editorial Nov 2026

Design is Everything.

AbstractThe use of risk prediction models to guide clinical decision-making is becoming more common in practice. Evaluating their effectiveness is often done after implementation and without the benefit of an experimental design. Although evaluations based on observational data can yield useful information, they are pr...

Joseph W. Hogan · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.